Clinical Trials Logo

Safety Issues clinical trials

View clinical trials related to Safety Issues.

Filter by:

NCT ID: NCT06468943 Enrolling by invitation - Safety Issues Clinical Trials

Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Start date: July 1, 2023
Phase: Phase 2
Study type: Interventional

Aim of this study will evaluate the efficacy and safety of Polatuzumab Vedotin and Zanubrutinib in combination with R-CHP for newly diagnosed untreated Non-GCB DLBCL Patients with extranodal involvement.

NCT ID: NCT06460987 Completed - Safety Issues Clinical Trials

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Start date: December 1, 2022
Phase:
Study type: Observational

IgA nephropathy accounts for about 45 per cent of primary glomerular diseases in China and about 26 per cent of renal biopsies in patients with chronic failure.According to current guideline recommendations, there are limited indications for non-steroidal MRAs. Therefore clinical studies to explore the range of clinical indications for fenetyllone are warranted.

NCT ID: NCT06451146 Recruiting - Safety Issues Clinical Trials

Lower Silesian Orbital Atherectomy Registry (LOAR)

LOAR
Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

The Lower Silesian Orbital Atherectomy Registry (LOAR), is an observational registry collecting all consecutive cases of percutaneous coronary intervention (PCI) performed with the support of the Orbital Atherectomy Device due to the presence of calcified lesion in coronary arteries. Data will be collected in two cooperating cardiac centers (Department of Cardiology, The Copper Health Center, Lubin, Poland, and Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland).

NCT ID: NCT06448442 Not yet recruiting - Safety Issues Clinical Trials

A Pilot Study of Deep Cervical Lymphatic-venous Anastomosis in the Treatment of Alzheimer's Disease

Start date: August 1, 2024
Phase:
Study type: Observational

Alzheimer's disease (AD) is the most prevalent form of dementia, affecting 3-4% of the population over a lifetime. It's characterized by abnormal Amyloid-beta (Aβ) and tau protein expression and accumulation in the central nervous system, leading to amyloid plaques and neurofibrillary tangles. While current treatments can slow cognitive decline, there's no cure. The discovery of the "glymphatic-meningeal lymphatic" system has shed new light on cerebrospinal fluid circulation, showing it has a similar interstitial fluid system to peripheral lymphatic circulation. This system helps clear waste and transport nutrients in the brain, known as the glymphatic phenomenon. The deep cervical lymph nodes, part of this system, are crucial for cerebrospinal fluid drainage and are linked to the clearance of AD-related proteins. Aging and inflammation can impair deep cervical lymph node function, increasing cerebrospinal fluid drainage pressure and potentially contributing to AD progression. Lymphatic anastomosis, a surgical technique used for lymphedema and other conditions, is being explored as a potential treatment to alleviate neurodegenerative disease by reducing cerebrospinal fluid pressure and clearing metabolic waste.

NCT ID: NCT06446778 Enrolling by invitation - Safety Issues Clinical Trials

Haemodynamic Mechanisms and Multicentre Prospective Cohort Study of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms. Evaluation of the Safety and Efficacy of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms

Start date: September 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study aims to collect clinical, laboratory, and imaging data from patients with unruptured intracranial aneurysms, and collect blood or urine samples for cotinine testing. The enrolled patients underwent Pipeline implantation. The purpose is to study the effect after Pipelineline implantation.

NCT ID: NCT06442293 Not yet recruiting - Safety Issues Clinical Trials

Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

This study is designed to evaluate the safety and tolerability of two distinct dietary supplement beverage formulations designed to maintain normal blood pressure. In this study, safety and tolerability will be assessed among otherwise healthy, normotensive individuals.

NCT ID: NCT06394505 Completed - Safety Issues Clinical Trials

Operating Room Nurses' Risks and Perceptions of Safety Climate

Start date: March 1, 2024
Phase:
Study type: Observational

One of the leading elements in providing safe healthcare is to maintain employee health and safety. Hazards in the working environments of healthcare professionals threaten employee safety and cause errors in patient care. In this case, healthcare professionals working in a safe environment means that patients receive service in a safe environment. Safety climate is the perception of employees of the policies, procedures and practices that exist to ensure safety in the workplace and is an important element for the formation of a safety culture in the workplace. There are many factors that determine the perception of safety climate. These factors can be listed as the type and size of the organization, the occupational risks that employees are exposed to at work, the way occupational safety is managed, the gender, seniority of employees, and their position in the organization.

NCT ID: NCT06384989 Not yet recruiting - Safety Issues Clinical Trials

Safety-Enhancing Motor Vehicle Child Safety Seat

Start date: May 1, 2024
Phase:
Study type: Observational

This study aims to assess the usability of a load leg design for caregivers who must install the child safety seat into a vehicle. The specific aims are to quantify any errors committed by the participants while installing the car seat and to assess participants' opinions on the car seat's load leg design.

NCT ID: NCT06383377 Recruiting - Safety Issues Clinical Trials

Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Start date: April 26, 2024
Phase: N/A
Study type: Interventional

This investigation is a pre-market, prospective, multi-center, randomized, single blinded, parallel controlled clinical investigation performed in at least 5 clinical centers for confirmatory purposes of the use of WHA as intended in the filling of extraction sockets to enhance preservation of the alveolar socket.

NCT ID: NCT06378125 Recruiting - Safety Issues Clinical Trials

Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes

Start date: December 19, 2022
Phase: Phase 1
Study type: Interventional

A double-blind, randomised, placebo-controlled, single-ascending and multiple-ascending dose trial to evaluate the safety and pharmacokinetics of oral controlled-ileal-release nicotinic acid (CIR-NA) compared to immediate-release nicotinic acid and placebo in healthy subjects and subjects with prediabetes.